Chemoinformaics analysis of 6,7-DEHYDROROYLEANONE
| Molecular Weight | 314.425 | nRot | 1 |
| Heavy Atom Molecular Weight | 288.217 | nRig | 17 |
| Exact Molecular Weight | 314.188 | nRing | 3 |
| Solubility: LogS | -4.145 | nHRing | 0 |
| Solubility: LogP | 5.492 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 53.1426 |
| nHD | 1 | BPOL | 27.8194 |
| QED | 0.508 |
| Synth | 4.261 |
| Natural Product Likeliness | 2.565 |
| NR-PPAR-gamma | 0.961 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.292 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.861 |
| MDCK | 0.0000253 |
| BBB | 0.02 |
| PPB | 1.00041 |
| VDSS | 3.26 |
| FU | 0.017513 |
| CYP1A2-inh | 0.513 |
| CYP1A2-sub | 0.654 |
| CYP2c19-inh | 0.277 |
| CYP2c19-sub | 0.555 |
| CYP2c9-inh | 0.495 |
| CYP2c9-sub | 0.903 |
| CYP2d6-inh | 0.422 |
| CYP2d6-sub | 0.51 |
| CYP3a4-inh | 0.301 |
| CYP3a4-sub | 0.33 |
| CL | 8.343 |
| T12 | 0.156 |
| hERG | 0.024 |
| Ames | 0.083 |
| ROA | 0.253 |
| SkinSen | 0.937 |
| Carcinogencity | 0.311 |
| EI | 0.886 |
| Respiratory | 0.934 |
| NR-Aromatase | 0.876 |
| Antiviral | No |
| Prediction | 0.709933 |